Lakefront Biotherapeutic...【LKFT】銘柄情報

Lakefront Biotherapeutics NV (LKFT) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

24.40

( 1.33% )

買値

23.30

売値

24.60

出来高

65,336

24.16 日の範囲 24.56

22.62 52 週間の範囲 24.56

時価総額

1.608B

前日終値

24.08

始値

24.20

時刻

500

24.4

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

77,581 €

発行済株式数

65,897,071

配当利回り

PER

3.3

1 株当たり利益 (EPS)

7.42

歳入

1.04B

純利益

488.78M

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG51... Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium. 詳細を表示

セクター

業界

ウェブサイト

lakefrontbio.com

本社

Mechelen, Belgium

設立

1999

Lakefront Biotherapeutics NV is listed in the sector of the ユーロネクスト with ticker LKFT. The last closing price for Lakefront Biotherapeutic... was 24.08 €. Over the last year, Lakefront Biotherapeutic... shares have traded in a share price range of 22.62 € to 24.56 €.

Lakefront Biotherapeutic... currently has 65,897,071 shares in issue. The market capitalisation of Lakefront Biotherapeutic... is 1.61 € billion. Lakefront Biotherapeutic... has a price to earnings ratio (PE ratio) of 3.30.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.28	1.16086235489	24.12	24.56	23.1	78820	23.97348059	DE
4	0.9	3.82978723404	23.5	24.56	22.62	63262	23.72264665	DE
12	0.9	3.82978723404	23.5	24.56	22.62	63262	23.72264665	DE
26	0.9	3.82978723404	23.5	24.56	22.62	63262	23.72264665	DE
52	0.9	3.82978723404	23.5	24.56	22.62	63262	23.72264665	DE
156	0.9	3.82978723404	23.5	24.56	22.62	63262	23.72264665	DE
260	0.9	3.82978723404	23.5	24.56	22.62	63262	23.72264665	DE